RISKIFIED LTD-A (RSKD)

IL0011786493 - Common Stock

4.71  +0.01 (+0.21%)

After market: 4.71 0 (0%)

Fundamental Rating

5

RSKD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. While RSKD has a great health rating, there are worries on its profitability. RSKD is growing strongly while it is still valued neutral. This is a good combination!



1

1. Profitability

1.1 Basic Checks

In the past year RSKD was profitable.
In the past year RSKD had a positive cash flow from operations.
RSKD had negative earnings in each of the past 5 years.
In multiple years RSKD reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -8.45%, RSKD perfoms like the industry average, outperforming 44.37% of the companies in the same industry.
With a Return On Equity value of -10.42%, RSKD perfoms like the industry average, outperforming 51.41% of the companies in the same industry.
Industry RankSector Rank
ROA -8.45%
ROE -10.42%
ROIC N/A
ROA(3y)-18.91%
ROA(5y)-15.18%
ROE(3y)-22.29%
ROE(5y)-19.7%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of RSKD (52.38%) is worse than 66.90% of its industry peers.
In the last couple of years the Gross Margin of RSKD has declined.
The Profit Margin and Operating Margin are not available for RSKD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.14%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

RSKD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RSKD has been increased compared to 1 year ago.
There is no outstanding debt for RSKD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

RSKD has an Altman-Z score of 4.75. This indicates that RSKD is financially healthy and has little risk of bankruptcy at the moment.
RSKD's Altman-Z score of 4.75 is fine compared to the rest of the industry. RSKD outperforms 64.44% of its industry peers.
RSKD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.75
ROIC/WACCN/A
WACC9.55%

2.3 Liquidity

RSKD has a Current Ratio of 7.73. This indicates that RSKD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 7.73, RSKD belongs to the best of the industry, outperforming 91.90% of the companies in the same industry.
A Quick Ratio of 7.73 indicates that RSKD has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 7.73, RSKD belongs to the best of the industry, outperforming 91.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.73
Quick Ratio 7.73

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 750.00% over the past year.
RSKD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.47%.
The Revenue has been growing by 20.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.25%
Revenue 1Y (TTM)9.47%
Revenue growth 3Y20.59%
Revenue growth 5YN/A
Sales Q2Q%8.2%

3.2 Future

RSKD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 76.60% yearly.
The Revenue is expected to grow by 10.86% on average over the next years. This is quite good.
EPS Next Y273.91%
EPS Next 2Y112.95%
EPS Next 3Y76.6%
EPS Next 5YN/A
Revenue Next Year8.13%
Revenue Next 2Y9.61%
Revenue Next 3Y10.86%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 36.23, which means the current valuation is very expensive for RSKD.
Based on the Price/Earnings ratio, RSKD is valued a bit cheaper than the industry average as 68.66% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 30.45. RSKD is around the same levels.
A Price/Forward Earnings ratio of 20.77 indicates a rather expensive valuation of RSKD.
RSKD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. RSKD is cheaper than 77.11% of the companies in the same industry.
RSKD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 36.23
Fwd PE 20.77

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, RSKD is valued a bit cheaper than the industry average as 72.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 31.62
EV/EBITDA N/A

4.3 Compensation for Growth

RSKD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
RSKD's earnings are expected to grow with 76.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y112.95%
EPS Next 3Y76.6%

0

5. Dividend

5.1 Amount

RSKD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RISKIFIED LTD-A

NYSE:RSKD (9/18/2024, 8:26:36 PM)

After market: 4.71 0 (0%)

4.71

+0.01 (+0.21%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap803.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 36.23
Fwd PE 20.77
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.45%
ROE -10.42%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 52.38%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 7.73
Quick Ratio 7.73
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)750%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y273.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.47%
Revenue growth 3Y20.59%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y